Hysolv UK launches new swine flu vaccination
The new vaccine protects against the pandemic strain of flu pdmH1N1.
A new swine flu vaccination has been launched by Hysolv Animal Health UK.
In a press release, Hysolv said the vaccine - Respiporc FLUpanH1N1 - protects against the pandemic strain of flu pdmH1N1, which is prevalent in the British Isles.
Two 1ml doses of the inactivated vaccine can be injected intramuscularly three weeks apart to pigs over the age of 56 days, providing immunisation to the majority of animals within seven days.
Developed by IDT Biologika, the vaccine has already proved a success in Germany, where 1.7 million doses have been prescribed. Field trials revealed that vaccination not only protected against clinical signs of influenza, it also resulted in improvements in reproduction and piglet performance.
Hysolv is strongly advising that Respiporc FLUpanH1N1 is used in conjunction with its existing vaccine, Respiporc FLU3. This is because Respiporc FLU3 gives protection against three other strains of swine flu (H1N1, H1N2 and H3N2).
‘When used together, the two vaccines protect pigs against the most relevant strains in the British Isles,” the company said.
FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.
